Marc De Hert, MD, PhD, University Psychiatric Centre, KU Leuven, campus Kortenberg Leuvensesteenweg 517, 3070 Kortenberg, Belgium. Email: [email protected]; Davy Vancampfort, PT, MSc, University Psychiatric Centre, KU Leuven campus Kortenberg, Leuvensesteenweg, Kortenberg and Department of Rehabilitation Sciences, Faculty of Kinesiology and Rehabilitation Sciences, Catholic University Leuven, Heverlee, Belgium; Christoph U. Correll, The Zucker Hillside Hospital, Glen Oaks, and Albert Einstein College of Medicine, Bronx, New York, USA; Joseph Peuskens, MD, PhD, K. Sweers, RN, University Psychiatric Centre, KUL campus Kortenberg, Leuvensesteenweg, Kortenberg, Belgium; Ruud van Winkel, MD, PhD, University Psychiatric Centre, KU Leuven campus Kortenberg, Leuvensesteenweg, Kortenberg, Belgium, and Department of Psychiatry and Neuropsychology, EURON, South Limburg Mental Health Research and Teaching Network, Maastricht University Medical Centre, Maastricht, The Netherlands; Alex J. Mitchell, MRCPsych, Leicester General Hospital, Leicester Partnership Trust, and Department of Cancer & Molecular Medicine, Leicester Royal Infirmary, University of Leicester, UK
Declaration of interest: M.D.H has been a consultant for, received grant/research support and honoraria from, and been on the speakers/advisory boards of AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Janssen-Cilag, Lundbeck JA, Pfizer and Sanofi Aventis.
